FDA Grants Approval for Atropine Sulfate ANDA219996
The FDA has granted approval for ANDA219996, a generic version of Atropine Sulfate, submitted by Gland.
Asset / Drug
Drug and asset intelligence for Gland with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.